Delivering RNAi Therapeutics
Tekmira is a leader in the development of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's three lead RNAi product candidates target cholesterol management, cancer and Ebola infection. In addition to its pipeline of products, Tekmira has partnership agreements with leading pharmaceutical companies, such as Alnylam and Roche, to provide its innovative RNAi delivery technology for the development of its partners’ RNAi products. Click here to learn more about Tekmira's technology.
Site Map Copyright©2008 Tekmira Pharmaceuticals Corp. All rights reserved. See legal terms for use of site.